Cheap, Lazy Investing™

Bought at 5.04.  Analysts have it at 10. Down for a minor FDA issue.  If it blows over, should be able to double the money in 24 months.

Tags: Spectrum Pharmaceuticals, SPPI

This entry was posted on Monday, October 12th, 2009 at 11:36 pm and is filed under Investment Diary. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.